DrugPatentWatch Database Preview
Email this page to a colleague
« Back to Dashboard
Vintafolide is an investigational drug.
There have been 9 clinical trials for Vintafolide. The most recent clinical trial was a Phase 2 trial, which was initiated on September 1st 2008.
The most common disease conditions in clinical trials are Neoplasms, Lung Neoplasms, and Breast Neoplasms. The leading clinical trial sponsors are Endocyte and [disabled in preview].
Recent Clinical Trials for Vintafolide
|Safety and Efficacy Study of Vintafolide and Vintafolide Plus Paclitaxel Compared to Paclitaxel Alone in Participants With Triple Negative Breast Cancer (TNBC) (MK-8109-004)||Endocyte||Phase 2|
|A Study of Vintafolide (MK-8109) in Participants With Advanced Solid Tumor (MK-8109-011)||Endocyte||Phase 1|
|A Study of MK-8109 (Vintafolide) Given Alone or With Chemotherapy in Participants With Advanced Cancers (MK-8109-001)||Endocyte||Phase 1|